The multilingual information below reflects the opinion of the Committee for Medicinal Products for Human Use, adopted on 21 January 2010. The formal decision from the European Commission is expected shortly.
English |
bălgarski |
|
español |
čeština |
|
dansk |
Deutsch |
|
eesti keel |
elliniká |
|
français |
italiano |
|
latviešu valoda |
lietuvių kalba |
|
magyar |
Malti |
|
Nederlands |
polski |
|
português |
română |
|
slovenčina |
slovenščina |
|
suomi |
svenskas |